CASI Pharmaceuticals (CB-5339) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
CASI Pharmaceuticals (CB-5339) General Information
Description
A novel VCP/p97 inhibitor based in Rockville, Maryland.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
- Rockville, MD
- United States
Corporate Office
- Rockville, MD
- United States
CASI Pharmaceuticals (CB-5339) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CASI Pharmaceuticals (CB-5339) FAQs
-
Where is CASI Pharmaceuticals (CB-5339) headquartered?
CASI Pharmaceuticals (CB-5339) is headquartered in Rockville, MD.
-
What industry is CASI Pharmaceuticals (CB-5339) in?
CASI Pharmaceuticals (CB-5339)’s primary industry is Drug Delivery.
-
Is CASI Pharmaceuticals (CB-5339) a private or public company?
CASI Pharmaceuticals (CB-5339) is a Private company.
-
What is CASI Pharmaceuticals (CB-5339)’s current revenue?
The current revenue for CASI Pharmaceuticals (CB-5339) is .
-
When was CASI Pharmaceuticals (CB-5339) acquired?
CASI Pharmaceuticals (CB-5339) was acquired on 21-Jul-2023.
-
Who acquired CASI Pharmaceuticals (CB-5339)?
CASI Pharmaceuticals (CB-5339) was acquired by CASI Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process